Hepatology highlights

by Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2016-01-01

Professor Andrew Burroughs

by Nahum Méndez-Sánchez, MD, MSc, PhD,FACG, AGAF.
Published 2014-05-01

After 14 years of work and progress

by Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2016-01-01

Hepatology Highlights

by Sofia Ornelas-Arroyo, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2014-03-01

The good, the bad and the ugly of the new treatments for hepatitis C virus

by Karen V. Silva-Vidal, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2014-09-01

New strategies for treating hepatic encephalopathy

by Cristina Gómez-Gutiérrez, María C. Manzano-Robleda, Misael Uribe, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2014-05-01

Alcohol effects on liver diseases: good or bad buddy?

by Varenka J. Barbero-Becerra, Jorge A. López-Velázquez, Vicente Sánchez-Valle, Misael Uribe, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF.
Published 2012-11-01

The prevalence of nonalcoholic fatty liver disease in the Americas

by Jorge A. López-Velázquez, Karen V. Silva-Vidal, Guadalupe Ponciano-Rodríguez, Norberte C. Chávez-Tapia, Marco Arrese, Misael Uribe, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2014-03-01

IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population

by Laura E. Martínez-Gómez, Norberto C. Chávez-Tapia, Ana I. Burguete-García, Nancy Aguilar-Olivos, Vicente Madrid-Marina, Margarita Román-Bahena, Citlalli Orbe-Orihuela, Uribe Misael, Nahum Méndez-Sánchez, MD, MSc,PhD, FACG, AGAF.
Published 2012-11-01

The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease

by Nancy E. Aguilar-Olivos, Daniel Carrillo-Córdova, Jesús Oria-Hernández, Vicente Sánchez-Valle, Guadalupe Ponciano-Rodríguez, Manuel Ramírez-Jaramillo, Fredy Chablé-Montero, Norberto C. Chávez-Tapia, Misael Uribe, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2015-07-01

An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver

by Norberto C. Chávez-Tapia, Ezequiel Ridruejo, Angelo Alves de Mattos, Fernando Bessone, Jorge Daruich, Juan F. Sánchez-Ávila, Hugo Cheinquer, Rodrigo Zapata, Misael Uribe, Francisco Bosques-Padilla, Adrián Gadano, Alejandro Soza, Milagros Dávalos-Moscol, Claudio Marroni, Linda Muñoz-Espinoza, Graciela Castro-Narro, Raymundo Paraná, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2013-03-01